Oxford Vacmedix has raised almost £1 million in funding, and is now looking to raise a second round of around £10 million. There are two centers, one in Oxford and one in China, working on this technology.
Q: What is your background? Why are you doing this?
A: I studied medicine in China, and then came to London and Harvard for my PhD and initial post doc post. I had been involved in immunology in London and the US, and was working on HIV and peptide segments for vaccines when I came to Oxford. I started looking into ways of producing these overlapping peptide segments, and starting using bacteria as a cheap method.
Read more (Enterprising Oxford website)